✦ LIBER ✦

Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years

✍ Scribed by Peter Iversen; Chris J. Tyrrell; Amir V. Kaisary; John B. Anderson; Luc Baert; Teuvo Tammela; Michael Chamberlain; Kevin Carroll; Karen Gotting-Smith; George R.P. Blackledge

Book ID: 119487194
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 871 KB
Volume: 51
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(98)00004-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiandrogen monotherapy in patients wit

Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years

✍ Peter Iversen; David G. McLeod; William A. See; Thomas Morris; Jon Armstrong; Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB

181 Bicalutamide (‘Casodex’) 150 mg as a

181 Bicalutamide (‘Casodex’) 150 mg as adjuvant to radical prostatectomy significantly increases progression-free survival in patients with early non-metastatic prostate cancer: Analysis at a median follow-up of 5.4 years

✍ M. Wirth; P. Iversen; D. McLeod; W. See; C. Morris; T. Morris; K. Carroll 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 237 KB